arrow
Back
P

Peter Hersey

calvary mater newcastle hospital

108H-index
639Paper Count
6.9WCitation Count
Published Papers 157
Publication Date
X and Y Differences in Melanoma Survival Between the Sexes
err2024-08-23
err0
errOAAI
errHersey, Peter; Tseng, Hsin-Yi; Alavi, Sara; Tiffen, Jessamy
errShare
errSave
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment
err2024-05-09
err1
errOAAI
errTseng, Hsin-Yi; Alavi, Sara; Gallagher, Stuart; McGuire, Helen M.; Hersey, Peter; Al Emran, Abdullah; Tiffen, Jessamy
errShare
errSave
Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma
err2022-05-01
err13
errOAAI
errAhmed, Farzana; Tseng, Hsin-Yi; Ahn, Antonio; Gunatilake, Dilini; Alavi, Sara; Eccles, Michael; Rizos, Helen; Gallagher, Stuart J.; Tiffen, Jessamy C.; Hersey, Peter; Al Emran, Abdullah
errShare
errSave
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006
err2021-11-01
err18
errOAAI
errHamid, Omid; Robert, Caroline; Daud, Adil; Carlino, Matteo S.; Mitchell, Tara C.; Hersey, Peter; Schachter, Jacob; V. Long, Georgina; Hodi, F. Stephen; Wolchok, Jedd D.; Arance, Ana; Grob, Jean Jacques; Joshua, Anthony M.; Weber, Jeffrey S.; Mortier, Laurent; Jensen, Erin; Diede, Scott J.; Moreno, Blanca Homet; Ribas, Antoni
errShare
errSave
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma
err2021-11-01
err17
errOAAI
errEggermont, Alexander M. M.; Meshcheryakov, Andrey; Atkinson, Victoria; Blank, Christian U.; Mandala, Mario; Long, Georgina, V; Barrow, Catherine; Di Giacomo, Anna Maria; Fisher, Rosalie; Sandhu, Shahneen; Kudchadkar, Ragini; Romero, Pablo Luis Ortiz; Svane, Inge Marie; Larkin, James; Puig, Susana; Hersey, Peter; Quaglino, Pietro; Queirolo, Paola; Stroyakovskiy, Daniil; Bastholt, Lars; Mohr, Peter; Hernberg, Micaela; Chiarion-Sileni, Vanna; Strother, Matthew; Hauschild, Axel; Yamazaki, Naoya; van Akkooi, Alexander Cj; Lorigan, Paul; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline
errShare
errSave
A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma
err2021-09-01
err11
PREAI
errAl Emran, Abdullah; Tseng, Hsin-Yi; Gunatilake, Dilini; Cook, Stuart J.; Ahmed, Farzana; Wang, Shudong; Hersey, Peter; Gallagher, Stuart J.; Tiffen, Jessamy C.
errShare
errSave
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
err2021-02-01
err66
errOAAI
errRobert, Caroline; Hwu, Wen-Jen; Hamid, Omid; Ribas, Antoni; Weber, Jeffrey S.; Daud, Adil, I; Hodi, F. Stephen; Wolchok, Jedd D.; Mitchell (Gangadhar), Tara C.; Hersey, Peter; Dronca, Roxana; Joseph, Richard W.; Boutros, Celine; Min, Le; Long, Georgina, V; Schachter, Jacob; Puzanov, Igor; Dummer, Reinhard; Lin, Jianxin; Ibrahim, Nageatte; Diede, Scott J.; Carlino, Matteo S.; Joshua, Anthony M.
errShare
errSave
Sex bias of females in survival from cancer and infections. Is X the answer?
err2021-01-19
err6
errOAAI
errEmran, Abdullah Al; Gallagher, Stuart J.; Tiffen, Jessamy C.; Hersey, Peter
errShare
errSave
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma
err2020-12-01
err47
errOAAI
errTiffen, Jessamy; Gallagher, Stuart J.; Filipp, Fabian; Gunatilake, Dilini; Al Emran, Abdullah; Cullinane, Carleen; Dutton-Register, Ken; Aoude, Lauren; Hayward, Nick; Chatterjee, Aniruddha; Rodger, Euan J.; Eccles, Michael R.; Hersey, Peter
errShare
errSave
Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma
err2020-09-01
err1
errOAAI
errHamid, O.; Joshua, A. M.; Hwu, W-J.; Ribas, A.; Weber, J.; Daud, A. S.; Hodi, F. S.; Wolchok, J. D.; Mitchell, T. C.; Hersey, P.; Dronca, R.; Joseph, R. W.; Boutros, C.; Min, L.; Long, G. V.; Schachter, J.; Lin, J.; Ibrahim, N.; Carlino, M.; Robert, C.
errShare
errSave
BET and CDK9 protein inhibitors: Novel epigenetic therapy to synergistically kill human melanoma cells
err2020-08-15
err0
PREAI
errAl Emran, Abdullah; Tseng, Hsin-Yi; Gunatilake, Dilini; Cook, Stuart; Tiffen, Jessamy; Gallagher, Stuart; Hersey, Peter
errShare
errSave
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
err2020-08-01
err62
errOAAI
errOwen, C. N.; Shoushtari, A. N.; Chauhan, D.; Palmieri, D. J.; Lee, B.; Rohaan, M. W.; Mangana, J.; Atkinson, V; Zaman, F.; Young, A.; Hoeller, C.; Hersey, P.; Dummer, R.; Khattak, M. A.; Millward, M.; Patel, S. P.; Haydon, A.; Johnson, D. B.; Lo, S.; Blank, C. U.; Sandhu, S.; Carlino, M. S.; Larkin, J. M. G.; Menzies, A. M.; Long, G., V
errShare
errSave
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma
err2020-04-24
err19
errOAAI
errTseng, Hsin-Yi; Dreyer, Jan; Al Emran, Abdullah; Gunatilake, Dilini; Pirozyan, Mehdi; Cullinane, Carleen; Dutton-Regester, Ken; Rizos, Helen; Hayward, Nicholas K.; McArthur, Grant; Hersey, Peter; Tiffen, Jessamy; Gallagher, Stuart
errShare
errSave
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
err2020-04-20
err25
errOAAI
errCebon, Jonathan S.; Gore, Martin; Thompson, John F.; Davis, Ian D.; McArthur, Grant A.; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P. Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P. N.; Hersey, Peter; Evans, T. R. Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G.; Corrie, Pippa G.; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M.; Endo-Munoz, Liliana; Tutuka, Candani S. A.; Venhaus, Ralph; Old, Lloyd J.; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan
errShare
errSave
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer
err2020-04-01
err15
errOAAI
errDizier, Benjamin; Callegaro, Andrea; Debois, Muriel; Dreno, Brigitte; Hersey, Peter; Gogas, Helen J.; Kirkwood, John M.; Vansteenkiste, Johan F.; Sequist, Lecia V.; Atanackovic, Djordje; Goeman, Jelle; van Houwelingen, Hans; Salceda, Susana; Wang, Fawn; Therasse, Patrick; Debruyne, Channa; Spiessens, Bart; Brichard, Vincent G.; Louahed, Jamila; Ulloa-Montoya, Fernando
errShare
errSave
Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients
err2020-03-10
err22
errOAAI
errPirozyan, Mehdi R.; McGuire, Helen M.; Al Emran, Abdullah; Tseng, Hsin-Yi; Tiffen, Jessamy C.; Lee, Jenny H.; Carlino, Matteo S.; Menzies, Alexander M.; Long, Georgina, V; Scolyer, Richard A.; de St Groth, Barbara Fazekas; Hersey, Peter
errShare
errSave
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
err2020-02-20
err11
errOAAI
errEmran, Abdullah Al; Tseng, Hsin-Yi; Coleman, Mikaela C.; Tiffen, Jessamy; Cook, Stuart; McGuire, Helen M.; Gallagher, Stuart; Feng, Carl; Hersey, Peter
errShare
errSave
Global DNA methylation levels regulate PD-L1 expression in melanoma
err2019-07-01
err0
PREAI
errChatterjee, Aniruddha; Ahn, Antonio; Rodger, Euan J.; Stockwell, Peter A.; Parry, Matthew; Motwani, Jyoti; Gallagher, Stuart J.; Shklovskaya, Elena; Tiffen, Jessamy; Hersey, Peter; Eccles, Michael R.
errShare
errSave
EZH2 epigenetically silences anti-tumor immunity in melanoma via dual histone and DNA methylation
err2019-07-01
err0
PREAI
errTiffen, Jessamy; Gunatilake, Dilini; Gallagher, Stuart; Hersey, Peter
errShare
errSave